These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32340935)

  • 1. Deep Convolutional Neural Networks and Transfer Learning for Measuring Cognitive Impairment Using Eye-Tracking in a Distributed Tablet-Based Environment.
    Haque RU; Pongos AL; Manzanares CM; Lah JJ; Levey AI; Clifford GD
    IEEE Trans Biomed Eng; 2021 Jan; 68(1):11-18. PubMed ID: 32340935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VisMET: a passive, efficient, and sensitive assessment of visuospatial memory in healthy aging, mild cognitive impairment, and Alzheimer's disease.
    Haque RU; Manzanares CM; Brown LN; Pongos AL; Lah JJ; Clifford GD; Levey AI
    Learn Mem; 2019 Mar; 26(3):93-100. PubMed ID: 30770466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of cognitive decline in mild cognitive impairment and Alzheimer's disease with a novel eye tracking test.
    Tadokoro K; Yamashita T; Fukui Y; Nomura E; Ohta Y; Ueno S; Nishina S; Tsunoda K; Wakutani Y; Takao Y; Miyoshi T; Higashi Y; Osakada Y; Sasaki R; Matsumoto N; Kawahara Y; Omote Y; Takemoto M; Hishikawa N; Morihara R; Abe K
    J Neurol Sci; 2021 Aug; 427():117529. PubMed ID: 34130064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye Tracking During Visual Paired-Comparison Tasks: A Systematic Review and Meta-Analysis of the Diagnostic Test Accuracy for Detecting Cognitive Decline.
    Boujelbane MA; Trabelsi K; Salem A; Ammar A; Glenn JM; Boukhris O; AlRashid MM; Jahrami H; Chtourou H
    J Alzheimers Dis; 2024; 99(1):207-221. PubMed ID: 38640158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
    Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
    Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Learning-Based Eye-Tracking Analysis for Diagnosis of Alzheimer's Disease Using 3D Comprehensive Visual Stimuli.
    Zuo F; Jing P; Sun J; Duan J; Ji Y; Liu Y
    IEEE J Biomed Health Inform; 2024 May; 28(5):2781-2793. PubMed ID: 38349825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatio-temporal convolution for classification of alzheimer disease and mild cognitive impairment.
    Turhan G; Küçük H; Isik EO
    Comput Methods Programs Biomed; 2022 Jun; 221():106825. PubMed ID: 35636355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Alzheimer's Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network.
    Zhang P; Lin S; Qiao J; Tu Y
    Sensors (Basel); 2021 Nov; 21(22):. PubMed ID: 34833710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data.
    Kang MJ; Kim SY; Na DL; Kim BC; Yang DW; Kim EJ; Na HR; Han HJ; Lee JH; Kim JH; Park KH; Park KW; Han SH; Kim SY; Yoon SJ; Yoon B; Seo SW; Moon SY; Yang Y; Shim YS; Baek MJ; Jeong JH; Choi SH; Youn YC
    BMC Med Inform Decis Mak; 2019 Nov; 19(1):231. PubMed ID: 31752864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-Stage Alzheimer's Disease Categorization Using PET Neuroimaging Modality and Convolutional Neural Networks in the 2D and 3D Domains.
    Tufail AB; Anwar N; Othman MTB; Ullah I; Khan RA; Ma YK; Adhikari D; Rehman AU; Shafiq M; Hamam H
    Sensors (Basel); 2022 Jun; 22(12):. PubMed ID: 35746389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-model and multi-slice ensemble learning architecture based on 2D convolutional neural networks for Alzheimer's disease diagnosis.
    Kang W; Lin L; Zhang B; Shen X; Wu S;
    Comput Biol Med; 2021 Sep; 136():104678. PubMed ID: 34329864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of transfer learning on 3D deep learning convolutional neural network segmentation of the hippocampus in mild cognitive impairment and Alzheimer disease subjects.
    Balboni E; Nocetti L; Carbone C; Dinsdale N; Genovese M; Guidi G; Malagoli M; Chiari A; Namburete AIL; Jenkinson M; Zamboni G
    Hum Brain Mapp; 2022 Aug; 43(11):3427-3438. PubMed ID: 35373881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Assessment of Resting-State for Mild Cognitive Impairment Detection: A Functional Near-Infrared Spectroscopy and Deep Learning Approach.
    Yang D; Hong KS
    J Alzheimers Dis; 2021; 80(2):647-663. PubMed ID: 33579839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Alzheimer's Disease Using Ensemble of Deep Neural Networks Trained Through Transfer Learning.
    Tanveer M; Rashid AH; Ganaie MA; Reza M; Razzak I; Hua KL
    IEEE J Biomed Health Inform; 2022 Apr; 26(4):1453-1463. PubMed ID: 34033550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
    Nagaraj S; Duong TQ
    J Alzheimers Dis; 2021; 80(3):1079-1090. PubMed ID: 33646166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment.
    Wilcockson TDW; Mardanbegi D; Xia B; Taylor S; Sawyer P; Gellersen HW; Leroi I; Killick R; Crawford TJ
    Aging (Albany NY); 2019 Aug; 11(15):5389-5398. PubMed ID: 31375642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Patient-Reported Symptoms from an Online Symptom Tracking Tool for Dementia Severity Staging: Development and Validation of a Machine Learning Approach.
    Shehzad A; Rockwood K; Stanley J; Dunn T; Howlett SE
    J Med Internet Res; 2020 Nov; 22(11):e20840. PubMed ID: 33174853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual Search Efficiency in Mild Cognitive Impairment and Alzheimer's Disease: An Eye Movement Study.
    Pereira MLGF; Camargo MVZA; Bellan AFR; Tahira AC; Dos Santos B; Dos Santos J; Machado-Lima A; Nunes FLS; Forlenza OV
    J Alzheimers Dis; 2020; 75(1):261-275. PubMed ID: 32250291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.